Enact Holdings, Inc. filings document the formal disclosures of a U.S. private mortgage insurance company. Form 8-K reports furnish quarterly and annual operating results, press releases, and financial supplements covering mortgage insurance performance, capital sufficiency, insurance in force, book value, and related financial measures.
The company's regulatory filings also cover proxy governance, board and stockholder voting matters, executive compensation, capital-return actions, stock repurchase arrangements involving Genworth Financial, and financing agreements such as its revolving credit facility. These records describe Enact's public-company governance, capital structure, liquidity arrangements, and material events tied to its mortgage insurance operations.
Enact Holdings insider transaction: Genworth Holdings, Inc., a reporting person and the company's majority shareholder, sold 648,312 shares of Enact Holdings common stock on 08/29/2025 at a per-share price of $37.1842. The sale was effected pursuant to a Share Repurchase Agreement between Enact and Genworth dated April 30, 2025, a copy of which is available in the issuer's SEC filings at the provided link. After this reported disposition, Genworth Holdings beneficially owns 118,873,450 shares, representing approximately 81% of Enact's outstanding common stock. The Form 4 was signed by Lisa J. Baldyga, Vice President and Treasurer, on behalf of Genworth Holdings, Inc.
Rohit Gupta, President and CEO and a director of Enact Holdings, Inc. (ticker: ACT), reported three separate open-market sales of the issuer's common stock executed on 08/27/2025, 08/28/2025 and 08/29/2025. The filings show dispositions of 11,039, 17,856 and 4,000 shares, respectively, at weighted-average sale prices of $38.18, $37.59 and $37.73 per share. Following the transactions, the reporting person beneficially owned 369,755 shares. The Form 4 is signed by a power of attorney for the reporting person.
Enact Holdings, Inc. (ACT) filed a Form 144 disclosing a proposed sale of 86,406 common shares through J.P. Morgan Securities LLC on 08/27/2025 on the NYSE. The filing reports an aggregate market value of $749,140 for the proposed sale and shows 410,433,925 shares outstanding.
The shares were acquired as compensation: 59,080 shares on 03/25/2024 and 27,326 shares on 03/01/2024. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
Enact Holdings, Inc. (ACT) Form 144 notice of proposed sale. The filer notified the market of an intended sale of 32,895 shares of common stock through J.P. Morgan Securities LLC on an approximate sale date of 08/27/2025 on NASDAQ, with an aggregate market value reported as $1,254,286. The shares were acquired from the issuer as compensation on 02/09/2024 (21,482 shares) and 02/11/2024 (11,413 shares). The filing states there were no securities sold by the person in the past three months and includes the standard representation that the seller knows of no undisclosed material adverse information about the issuer.
Enact Holdings insider Form 4: Michael Derstine, Executive Vice President and Chief Risk Officer, reported a disposition of 3,500 shares of Enact Holdings, Inc. (ACT) on 08/19/2025. The transaction is coded G and recorded at a price of $0, with the filer explaining the shares were a charitable donation to a donor advised fund. After the reported transaction, Derstine directly beneficially owns 30,271 shares. The Form 4 was submitted under power of attorney by Joe Jacumin and dated 08/21/2025. The filing documents a non-cash transfer of shares for charitable purposes and a modest reduction in the reporting officer’s direct holdings.